Giulia Kennedy is a seasoned professional with significant experience in the biotechnology and cancer research sectors. As a Co-Founder and Chief Scientific Officer at PinkDx, Inc., and a Board Member at both Encodia and Acuamark Diagnostics, Inc., Giulia demonstrates a strong leadership presence. In addition, Giulia serves on the AACR Cancer Evolution Working Group Steering Committee and holds a position on the Board of Directors for Astarte Medical. Giulia's academic credentials include a Postdoctoral Fellowship in Genome Sciences/Genomics from the University of California, San Francisco, and a Ph.D. in Biochemistry from Case Western Reserve University School of Medicine.